Uppsala, Sweden

Lars Terenius

USPTO Granted Patents = 2 

 

Average Co-Inventor Count = 5.0

ph-index = 2

Forward Citations = 53(Granted Patents)


Company Filing History:


Years Active: 2001-2007

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations of Lars Terenius

Introduction

Lars Terenius is a notable inventor based in Uppsala, Sweden. He has made significant contributions to the field of biochemistry, particularly in the study of amyloid peptides. With a total of two patents to his name, Terenius has focused on developing compounds that have the potential to inhibit the polymerization of amyloid beta peptides.

Latest Patents

Terenius's latest patents include innovative compounds designed to bind to the KLVFF-sequence of amyloid beta. These compounds are of great interest for their potential applications in inhibiting the polymerization of amyloid beta peptides. They serve as model substances for the synthesis of amyloid beta peptide-ligands and as tools for identifying other organic compounds with similar functional properties. Additionally, these compounds can act as ligands for the detection of amyloid deposits using techniques such as positron emission tomography (PET).

Career Highlights

Throughout his career, Lars Terenius has worked with various organizations, including Karolinska Innovations AB and Neurochem Limited. His work has been instrumental in advancing the understanding of amyloid-related diseases and developing potential therapeutic strategies.

Collaborations

Terenius has collaborated with notable colleagues such as Christer Nordstedt and Johan Thyberg. These partnerships have contributed to the success of his research and innovations in the field.

Conclusion

Lars Terenius is a distinguished inventor whose work on amyloid beta peptides has the potential to impact the medical field significantly. His innovative patents and collaborations highlight his commitment to advancing biochemistry and addressing critical health challenges.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…